Bempedoic acid is a lipid-lowering agent used to treat hypercholesterolemia. It inhibits ATP-citrate lyase, an enzyme involved in cholesterol synthesis, thereby reducing low-density lipoprotein cholesterol levels.Bempedoic acid is a lipid-lowering agent used to treat hypercholesterolemia. It inhibits ATP-citrate lyase, an enzyme involved in cholesterol synthesis, thereby reducing low-density lipoprotein cholesterol levels. It is grouped under the following drug class(es): Cholesterol-reducing agents and Lipid-lowering agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Nexletol and Nilemdo. Its PubChem CID is 10472693.
Bempedoic acid
| CAS No | 738606-46-7 |
|---|---|
| Molecular Formula | C19H36O5 |
| Molecular Weight | 344.8 g/mol |
| Synonyms | 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bempedoic acid is a lipid-lowering agent used to treat hypercholesterolemia. Bempedoic acid is a lipid-lowering agent used to treat hypercholesterolemia. It inhibits ATP-citrate lyase, an enzyme involved in cholesterol synthesis, thereby reducing low-density lipoprotein cholesterol levels.
The listed CAS number is 738606-46-7.
The listed molecular formula is C19H36O5.
The listed molecular weight is 344.8 g/mol.
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid.
The source lists Nexletol and Nilemdo.